Indeed, all associations became far from genome-wide significant (P > 0.006) when the model that includes positive and negative SS patients was adjusted by anti-Ro/SSA presence or when only patients negative for SSA were contrasted with controls (P > 0.05). The gene discussed is CALR; the disease is synovial sarcoma.